Prism BioLab
Fujisawa
About Prism BioLab
PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $27.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2024)
- Website: prismbiolab.comja
- Phone: +81 04-6653-8383
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/prism-biolab-25576 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.